AGÕæÈ˹ٷ½

STOCK TITAN

Uipath Inc SEC Filings

PATH NYSE

Welcome to our dedicated page for Uipath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

UiPath’s automation story is written in its SEC filings. Each 10-K reveals how subscription licensing and cloud-based robots turn repetitive tasks into scalable revenue, while Form 4s track when executives buy or sell shares in a fast-moving RPA market. This page brings every disclosure together, from the smallest 8-K on product releases to the comprehensive proxy statement on executive compensation.

Stock Titan’s AI reads the dense language so you don’t have to. Need the UiPath quarterly earnings report 10-Q filing? We surface ARR, customer count, and cloud mix in plain English. Curious about UiPath insider trading Form 4 transactions? AGÕæÈ˹ٷ½-time alerts flag patterns before the market notices. Our AI-powered summaries translate revenue recognition notes, goodwill impairment tests, and segment performance into straightforward takeaways, making understanding UiPath SEC documents with AI effortless.

Here’s what you can explore:

  • Annual depth: UiPath annual report 10-K simplified with key automation metrics, risk factors, and cash-flow drivers.
  • Quarterly pulse: Side-by-side 10-Q comparisons for sequential growth and margin shifts, plus UiPath earnings report filing analysis.
  • Event trackers: UiPath 8-K material events explained within minutes of EDGAR release.
  • Insider lens: UiPath Form 4 insider transactions real-time and archived UiPath executive stock transactions Form 4.
  • Governance focus: The latest UiPath proxy statement executive compensation summarized for pay-performance alignment.

Whether you’re quantifying automation adoption or monitoring governance, Stock Titan delivers comprehensive coverage, AI-powered summaries, and immediate updates�UiPath SEC filings explained simply, every time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (PATH) Form 4 filing: Director Philippe Botteri received an annual grant of 16,064 Restricted Stock Units (RSUs) on 26 Jun 2025 under the company’s non-employee director compensation policy. Each RSU converts into one Class A share when vested. The award vests on the earlier of the next annual meeting or the first anniversary of the grant date, provided the director remains in service.

The RSUs were issued at a price of $0.00, so no cash changed hands and no open-market transaction occurred. Following the grant, Botteri’s beneficial ownership rises to 3,160,889 Class A shares. No derivative securities or additional transactions were reported. The filing contains no other material corporate developments or financial metrics and is considered routine, with negligible dilution relative to UiPath’s total share count.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

UiPath (NYSE:PATH) CEO, Chairman and 10% owner Daniel Dines filed a routine Form 4 reporting the sale of 45,000 Class A shares on 06/27/2025 at an average price of $12.78 under a Rule 10b5-1 trading plan, for proceeds of roughly $0.58 million.

Dines still beneficially owns about 30.8 million shares: 24.9 million directly, 5.6 million through Ice Vulcan Holding Ltd., and 240,000 held by his spouse. The sale represents less than 0.2% of his holdings and does not affect his control position. No derivative securities were involved, and no other material changes were disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UiPath (NYSE:PATH) filed a Form 4 disclosing that CEO, Chairman and 10% owner Daniel Dines sold 45,000 Class A shares on 26 Jun 2025 at an average price of $12.38, generating about $0.56 million. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

After the sale, Dines still beneficially owns roughly 30.8 million shares (direct, indirect and spouse holdings), so the disposal represents well under 1% of his position. No other transactions or derivative movements were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Uipath (PATH)?

The current stock price of Uipath (PATH) is $11.03 as of August 25, 2025.

What is the market cap of Uipath (PATH)?

The market cap of Uipath (PATH) is approximately 6.0B.
Uipath Inc

NYSE:PATH

PATH Rankings

PATH Stock Data

5.98B
418.16M
8.27%
81.56%
10.27%
Software - Infrastructure
Services-prepackaged Software
United States
NEW YORK